PHAR: Pharming Group N.V. ADS, each representing 10 ordinary shares Company Profile & Statistics

About

Pharming Group N.V. is a commercial stage biopharmaceutical company. It engages in developing protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs. The company's product portfolio includes C1INH. Pharming Group N.V. is based in Leiden, The Netherlands.

Info & Links

CEO

Sijmen de Vries

Headquarters

DARWINWEG 24
LEIDEN, P7 2333 CR, NETHERLANDS

Auditor

Deloitte Accountants B.V.

Share holders

Employees

382

Pharming Group N.V. ADS, each representing 10 ordinary shares Statistics

Valuation Measures

Market Capitalization²

544.75M

Enterprise Value

572.21M

Enterprise Value/EBITDA(ttm)

338.58

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.13

Price to Book(mrq)

2.69

Price to Cash(ytd)

91.82

Profitability

Gross Margin(ttm)

89.05%

Operating Margin(ttm)

-5.83%

Profit Margin(ttm)

-7.30%

Return on Equity(ttm)

-7.65%

Return on Invested Capital(ttm)

-7.63%

Return on Assets(ttm)

-3.82%

Income Statement

Revenue(ttm)

285.75M

Revenue Per Share(ttm)

Gross Profit(ttm)

255.40M

EBITDA(ttm)³

1.69M

Net Income Available to Common(ttm)

-17.79M

Diluted EPS(ttm)

-0.26

Share Statistics

Beta (5Y Monthly)

-0.10

52-Week Change

-27.13%

S&P 500 52-Week Change

4.44%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

66.62M

% Held by Insiders

2.07%

% Held by Institutions

0.03%

Balance Sheet

Total Cash(mrq)

167.89M

Total Cash Per Share(mrq)

Total Debt(mrq)

82.40M

Total Debt/Equity(mrq)

42.26%

Current Ratio(mrq)

3.53%

Quick Ratio(mrq)

2.76%

Book Value Per Share(mrq)

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.22

Free Cash Flow(ytd)

-11.79M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PHAR

Pharming Group N.V. ADS, each representing 10 ordinary shares

Pharming Group N.V. ADS, each representing 10 ordinary shares Profile